3D Printing for Rapid Clinical Drug Development and CDMO Implementation

June 10th, 2025

Nicola Parisi, Founder of Uroboro Consulting, and Carlos Bendicho, Research Director at FABRX, explore how 3D printing streamlines first-in-human clinical studies through flexible drug dosing and its integration in CDMO processes